Congress Weighs Biosecure Act to Restrict Blacklisted Chinese Biotech Firms Over DNA Collection

Dec 5, 2024, 03:39 PM

The U.S. Congress is considering the Biosecure Act, a legislative measure aimed at restricting blacklisted Chinese biotechnology firms linked to the Chinese military from operating in the United States. These companies are allegedly collecting DNA data from American citizens and using it for military experiments, including the development of bio-weapons and complex viruses. The bill has passed the House of Representatives and now awaits Senate approval. Supporters of the bill argue that it is essential for safeguarding national security, economic independence, and preventing potential threats posed by Chinese military-linked entities. Lawmakers are reportedly exploring a potential compromise to advance the legislation.